Search research articles
Contact Us
Filters
Showing results (21-30 of 154) with videos related to
Page
of 16
Sort By:
International Journal of Pharmaceutics
|
April 16, 2003
5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties
N Kaiser, A Kimpfler, U Massing, et al.
Oncogene
|
June 29, 2001
Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors
G Landberg, H Ostlund, N H Nielsen, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 21, 2007
Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)
A M Burger, P M Loadman, D E Thurston, et al.
Journal of Chemotherapy (Florence, Italy)
|
November 26, 2009
Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents
V Smith, F Dai, M Spitz, et al.
International Immunology
|
May 1, 1997
Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniae
W X Guo, A M Burger, R T Fischer, et al.
Cancer Chemotherapy and Pharmacology
|
April 27, 2002
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels
R Moog, A M Burger, M Brandl, et al.
Oncogene
|
June 17, 1998
Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas
A M Burger, X Zhang, H Li, et al.
International Journal of Oncology
|
October 17, 1998
Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells
A M Burger, H H Fiebig, M R Kuettel, et al.
Cancer Research
|
December 5, 2000
Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development
R M Phillips, A M Burger, P M Loadman, et al.
Cancer Research
|
July 1, 1995
Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria
A M Burger, G Kaur, M C Alley, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 154) with videos related to
Sort By:
Page
of 16
International Journal of Pharmaceutics
|
April 16, 2003
5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties
N Kaiser, A Kimpfler, U Massing, et al.
Oncogene
|
June 29, 2001
Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors
G Landberg, H Ostlund, N H Nielsen, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 21, 2007
Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)
A M Burger, P M Loadman, D E Thurston, et al.
Journal of Chemotherapy (Florence, Italy)
|
November 26, 2009
Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents
V Smith, F Dai, M Spitz, et al.
International Immunology
|
May 1, 1997
Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniae
W X Guo, A M Burger, R T Fischer, et al.
Cancer Chemotherapy and Pharmacology
|
April 27, 2002
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels
R Moog, A M Burger, M Brandl, et al.
Oncogene
|
June 17, 1998
Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas
A M Burger, X Zhang, H Li, et al.
International Journal of Oncology
|
October 17, 1998
Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells
A M Burger, H H Fiebig, M R Kuettel, et al.
Cancer Research
|
December 5, 2000
Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development
R M Phillips, A M Burger, P M Loadman, et al.
Cancer Research
|
July 1, 1995
Tyrphostin AG17, [(3,5-Di-tert-butyl-4-hydroxybenzylidene)- malononitrile], inhibits cell growth by disrupting mitochondria
A M Burger, G Kaur, M C Alley, et al.
Page
of 16